I am...
- All
- HLH/FEL/FHL
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
Revised International Treatment Protocol for HLH-94 Clinical Trial
Jan-Inge Henter MD, PhD Astrid Lindgren Children’s Hospital – Stockholm, Sweden Award Amount: $30,000 Grant Awarded in:…
Genetic and Functional Studies on the Pathogenesis of FHL
Jan-Inge Henter MD, PhD (PI) and Bengt Fadeel MD Karolinska Hopital – Stockholm, Sweden Award Amount: $30,000…
Cytotoxic Cell Studies in Family Members of Patients with Hemophagocytic Lymphohistiocytosis (HLH) and Patients with Macrophage Activation Syndrome (MAS)
Alexandra Filipovich MD Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio USA Award Amount: $30,000 Grant Awarded…
Analysis of Gene Expression in HLH Patients Using DNA Microarrays
Janos Sumegi MD University of Nebraska Medical Center – Omaha, Nebraska USA Award Amount: $30,000 Grant Awarded…
LCH-III Clinical Trial
Nicole Grois MD St. Anna Children’s Hospital – Vienna, Austria Award Amount: $30,000 Grant Awarded in: 2001
Evaluation of Thalidomide for Treatment of Resistant Langerhans Cell Histiocytosis
Kenneth McClain MD, PhD Texas Children’s Hospital – Houston, Texas USA Award Amount: $30,000 Grant Awarded in:…
Analysis of the Tumor Necrosis Factor Receptor Pathway in LCH
Manfred B. Lutz PhD and Jens Oliver Funk MD University of Erlangen – Erlangen, Germany Award Amount:…